More Adherium Ltd. news
Adherium Ltd.ASX: ADR

Adherium receives US FDA 510k OTC clearance

Mar 27, 2018 at 3:32 AM EDT · Issued by Adherium Ltd.

Filed with ASX · Mar 27, 2018 at 3:32 AM EDT

On 6ix: 6ix.com/news/adherium-receives-us-fda-510k-otc-clearance

Adherium Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Adherium Ltd. on 6ix

Story so far

  • Adherium receives US FDA 510k clearanceSep 1, 2017

Earlier from Adherium

  • Asthma Adherence Management FindingsMar 7, 2018
  • Adherium Investor Conference CallFeb 6, 2018
  • Adherium Names Tim Houchin Vice President of SalesJan 25, 2018
  • Adherium Corporate Headquarters Opens in Silicon ValleyJan 18, 2018
  • Adherium Highlights Milestones AchievedDec 20, 2017

Later from Adherium

  • Adherium Announces Program with Vitalus HealthMay 1, 2018
  • Adherium launches new global brand HailieMay 16, 2018
  • Adherium Smartinhaler used in Global Mild-Asthma StudiesMay 21, 2018
  • Adherium Program with Connecticut Childrens Medical CenterJul 10, 2018
  • Adherium Receives Additional US FDA 510(k) ClearanceJul 26, 2018
All Adherium news releases↗

Follow Adherium into a list and get an email when it puts out news.

Follow Adherium
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer